Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Gastroesophageal Cancer × Drug Therapy × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 8 Colorectal Neoplasms 6 Breast Neoplasms 6 Stomach Neoplasms 5 Pancreatic Neoplasms 4 Sarcoma 3 Precision Cell Immunotherapy 3 Ovarian Neoplasms 3 Neoplasms 3 Neoplasm Metastasis 3 Lung Neoplasms 3 Hodgkin Disease 3 Glioblastoma 3 Wilms Tumor 2 Squamous Cell Carcinoma of Head and Neck 2 Mesothelioma, Malignant 2 Melanoma 2 Lymphoma 2 Leukemia, Myeloid, Acute 2 Head and Neck Neoplasms 2 Fallopian Tube Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Colonic Neoplasms 2 Cholangiocarcinoma 2 Carcinoma, Ovarian Epithelial 2 Virus Diseases 1 Vaccinia 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1

Interventions

relatlimab 1 Nivolumab 1 Drug Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07477444 2026-03-17

HER-OIC

Universitaire Ziekenhuizen KU Leuven

Phase 1/2 Not yet recruiting

Gastrointestinal

Gastroesophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡